UDCA has, therefore, been evaluated for the treatment of patients with PSC. Trials of UDCA at low doses (10–15 mg/kg per day and 17–20 mg/kg per day) have yielded inconclusive results in ...

However, since the FLINT study, the largest NASH Study to date, no drug ever came close to Obeticholic Acid. (ObA), except Ursodeoxycholic acid (UDCA). This systematic review of over 1548 randomized ...

Salk scientists discover that removing bile acid-creating protein BAAT and adding bile acid UDCA controls tumor growth in mice with liver cancer; UDCA dietary supplements may be quick solution to ...

has granted approval to the drug major Abbott India to conduct a phase-III clinical trial of Ursodeoxycholic Acid (UDCA) tablets 150 mg/300 mg/450 mg/600 mg. This came after Abbott India presented the ...